[Gene therapy for stroke].
Ooboshi
Hiroaki
H
Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University.
Ishikawa
Eiichi
E
Kumai
Yasuhiro
Y
Takada
Junichi
J
Ibayashi
Setsuro
S
D015740:Calcitonin Gene-Related Peptide / Q000627:therapeutic use; D016207:Cytokines / Q000235:genetics / Q000627:therapeutic use; D015316:Genetic Therapy / Q000379:methods / Q000639:trends; D005822:Genetic Vectors; D051100:Glial Cell Line-Derived Neurotrophic Factor / Q000235:genetics / Q000627:therapeutic use; D006801:Humans; D016753:Interleukin-10 / Q000235:genetics / Q000627:therapeutic use; D000078792:Midkine; D052250:Nitric Oxide Synthase Type III / Q000235:genetics / Q000627:therapeutic use; D009841:Oligonucleotides / Q000235:genetics / Q000627:therapeutic use; D020521:Stroke / Q000628:therapy*; D013345:Subarachnoid Hemorrhage / Q000628:therapy; D014780:Viruses
D016207:Cytokines; D051100:Glial Cell Line-Derived Neurotrophic Factor; D009841:Oligonucleotides; D016753:Interleukin-10; D000078792:Midkine; D052250:Nitric Oxide Synthase Type III; D015740:Calcitonin Gene-Related Peptide